<?xml version="1.0" encoding="iso-8859-1" standalone="no"?>
<!DOCTYPE GmsArticle SYSTEM "http://www.egms.de/dtd/2.0.34/GmsArticle.dtd">
<GmsArticle xmlns:xlink="http://www.w3.org/1999/xlink">
  <MetaData>
    <Identifier>dgkh000644</Identifier>
    <IdentifierDoi>10.3205/dgkh000644</IdentifierDoi>
    <IdentifierUrn>urn:nbn:de:0183-dgkh0006445</IdentifierUrn>
    <ArticleType>Research Article</ArticleType>
    <TitleGroup>
      <Title language="en">Prevalence of nosocomial infections in intensive care units and the role of the infection prevention and control team in implementing protective measures &#8211; a case study of a university hospital in Morocco</Title>
      <TitleTranslated language="de">Pr&#228;valenz nosokomialer Infektionen auf Intensivstationen und die Rolle des Teams f&#252;r die Infektionkontrollteams bei der Umsetzung von Schutzma&#223;nahmen &#8211; eine Fallstudie eines Universit&#228;tskrankenhauses in Marokko</TitleTranslated>
    </TitleGroup>
    <CreatorList>
      <Creator>
        <PersonNames>
          <Lastname>Arai</Lastname>
          <LastnameHeading>Arai</LastnameHeading>
          <Firstname>Mounir</Firstname>
          <Initials>M</Initials>
          <AcademicTitle>Prof. Dr.</AcademicTitle>
        </PersonNames>
        <Address>Higher Institute of Nursing and Health Technical Professions (ISPITS), Casablanca, Morocco; Phone: &#43;212666273147<Affiliation>Laboratory of Care, Health and Sustainable Development (2S2D)-Team: Care and Biology-Health, Higher Institute of Nursing and Health Technical Professions (ISPITS), Casablanca, Morocco</Affiliation><Affiliation>Laboratory of Chemistry-Biochemistry, Environment, Nutrition, and Health &#8211; Hassan II University, Faculty of Medicine and Pharmacy of Casablanca, Morocco</Affiliation></Address>
        <Email>arai.mounir83&#64;gmail.com</Email>
        <Creatorrole corresponding="yes" presenting="no">author</Creatorrole>
      </Creator>
      <Creator>
        <PersonNames>
          <Lastname>Ouhadous</Lastname>
          <LastnameHeading>Ouhadous</LastnameHeading>
          <Firstname>Mohamed</Firstname>
          <Initials>M</Initials>
        </PersonNames>
        <Address>
          <Affiliation>Laboratory of Chemistry-Biochemistry, Environment, Nutrition, and Health &#8211; Hassan II University, Faculty of Medicine and Pharmacy of Casablanca, Morocco</Affiliation>
        </Address>
        <Creatorrole corresponding="no" presenting="no">author</Creatorrole>
      </Creator>
      <Creator>
        <PersonNames>
          <Lastname>Salih</Lastname>
          <LastnameHeading>Salih</LastnameHeading>
          <Firstname>Sabah</Firstname>
          <Initials>S</Initials>
        </PersonNames>
        <Address>
          <Affiliation>Laboratory of Chemistry-Biochemistry, Environment, Nutrition, and Health &#8211; Hassan II University, Faculty of Medicine and Pharmacy of Casablanca, Morocco</Affiliation>
        </Address>
        <Creatorrole corresponding="no" presenting="no">author</Creatorrole>
      </Creator>
      <Creator>
        <PersonNames>
          <Lastname>Lajane</Lastname>
          <LastnameHeading>Lajane</LastnameHeading>
          <Firstname>Halima</Firstname>
          <Initials>H</Initials>
        </PersonNames>
        <Address>
          <Affiliation>Laboratory of Care, Health and Sustainable Development (2S2D)-Team: Care and Biology-Health, Higher Institute of Nursing and Health Technical Professions (ISPITS), Casablanca, Morocco</Affiliation>
        </Address>
        <Creatorrole corresponding="no" presenting="no">author</Creatorrole>
      </Creator>
      <Creator>
        <PersonNames>
          <Lastname>Gouifrane</Lastname>
          <LastnameHeading>Gouifrane</LastnameHeading>
          <Firstname>Rachid</Firstname>
          <Initials>R</Initials>
        </PersonNames>
        <Address>
          <Affiliation>Laboratory of Care, Health and Sustainable Development (2S2D)-Team: Care and Biology-Health, Higher Institute of Nursing and Health Technical Professions (ISPITS), Casablanca, Morocco</Affiliation>
        </Address>
        <Creatorrole corresponding="no" presenting="no">author</Creatorrole>
      </Creator>
      <Creator>
        <PersonNames>
          <Lastname>Abidi</Lastname>
          <LastnameHeading>Abidi</LastnameHeading>
          <Firstname>Omar</Firstname>
          <Initials>O</Initials>
        </PersonNames>
        <Address>
          <Affiliation>Laboratory of Care, Health and Sustainable Development (2S2D)-Team: Care and Biology-Health, Higher Institute of Nursing and Health Technical Professions (ISPITS), Casablanca, Morocco</Affiliation>
        </Address>
        <Creatorrole corresponding="no" presenting="no">author</Creatorrole>
      </Creator>
      <Creator>
        <PersonNames>
          <Lastname>Khaleq</Lastname>
          <LastnameHeading>Khaleq</LastnameHeading>
          <Firstname>Khalid</Firstname>
          <Initials>K</Initials>
        </PersonNames>
        <Address>
          <Affiliation>Laboratory of Chemistry-Biochemistry, Environment, Nutrition, and Health &#8211; Hassan II University, Faculty of Medicine and Pharmacy of Casablanca, Morocco</Affiliation>
        </Address>
        <Creatorrole corresponding="no" presenting="no">author</Creatorrole>
      </Creator>
    </CreatorList>
    <PublisherList>
      <Publisher>
        <Corporation>
          <Corporatename>German Medical Science GMS Publishing House</Corporatename>
        </Corporation>
        <Address>D&#252;sseldorf</Address>
      </Publisher>
    </PublisherList>
    <SubjectGroup>
      <SubjectheadingDDB>610</SubjectheadingDDB>
      <Keyword language="en">prevalence</Keyword>
      <Keyword language="en">nosocomial infections</Keyword>
      <Keyword language="en">intensive care units</Keyword>
      <Keyword language="en">infection control</Keyword>
      <Keyword language="en">quality improvement</Keyword>
      <Keyword language="en">Morocco</Keyword>
      <Keyword language="de">Pr&#228;valenz</Keyword>
      <Keyword language="de">nosokomiale Infektion</Keyword>
      <Keyword language="de">Intensivstationen</Keyword>
      <Keyword language="de">Infektionskontrolle</Keyword>
      <Keyword language="de">Qualit&#228;tsverbesserung</Keyword>
      <Keyword language="de">Marokko</Keyword>
    </SubjectGroup>
    <DatePublishedList>
      <DatePublished>20260320</DatePublished>
    </DatePublishedList>
    <Language>engl</Language>
    <License license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
      <AltText language="en">This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License.</AltText>
      <AltText language="de">Dieser Artikel ist ein Open-Access-Artikel und steht unter den Lizenzbedingungen der Creative Commons Attribution 4.0 License (Namensnennung).</AltText>
    </License>
    <SourceGroup>
      <Journal>
        <ISSN>2196-5226</ISSN>
        <Volume>21</Volume>
        <JournalTitle>GMS Hygiene and Infection Control</JournalTitle>
        <JournalTitleAbbr>GMS Hyg Infect Control</JournalTitleAbbr>
      </Journal>
    </SourceGroup>
    <ArticleNo>35</ArticleNo>
  </MetaData>
  <OrigData>
    <Abstract language="de" linked="yes"><Pgraph><Mark1>Einleitung:</Mark1>  Intensivstationen sind trotz ihres geringen Anteils an Betten ein gro&#223;es Reservoir f&#252;r multiresistente Bakterien (MDRO) und weisen eine hohe H&#228;ufigkeit nosokomialer Infektionen auf. Diese Studie zielt darauf ab, deren Pr&#228;valenz zu sch&#228;tzen, Risikofaktoren zu identifizieren, die verantwortlichen Mikroorganismen zu bestimmen und Pr&#228;ventionsma&#223;nahmen zur Eind&#228;mmung der Risiken aufzuzeigen.</Pgraph><Pgraph><Mark1>Methoden:</Mark1> Es wurde eine Fragebogen-basierte Querschnittsuntersuchung zur Pr&#228;valenz nosokomialer bei allen  Patienten, die mindestens 24 Stunden lang hospitalisiert waren, durchgef&#252;hrt. </Pgraph><Pgraph><Mark1>Ergebnisse:</Mark1> Von 50 eingeschlossenen Patienten wiesen 30,0&#37; eine nosokomiale Infektion auf. Die h&#228;ufigste Lokalisation war die Lunge. Von 18 Bakterienspecies, die bei 15 Patienten isoliert wurden, waren 66,7&#37; multiresistent. Die am h&#228;ufigsten isolierte Spezies war <Mark2>Acinetobacter baumannii</Mark2> (44,4&#37;) mit einer Resistenzrate von 100&#37; gegen Imepenem.</Pgraph><Pgraph><Mark1>Schlussfolgerung:</Mark1> Die Untersuchung erm&#246;glichte es, die H&#228;ufigkeit, die Risikofaktoren und die verantwortlichen Mikroorganismen zu identifizieren. Dieser Ansatz trug dazu bei, Pr&#228;ventionsma&#223;nahmen zu steuern die Kontrollma&#223;nahmen gegen diese Infektionen im Kontext von begrenzten Ressourcen zu verst&#228;rken.</Pgraph></Abstract>
    <Abstract language="en" linked="yes"><Pgraph><Mark1>Introduction:</Mark1> Despite their small number of beds, intensive care units are major reservoirs of multidrug-resistant bacteria (MDRO) and experience a high frequency of nosocomial infections. This study aims to estimate their prevalence, identify risk factors, determine the microorganisms responsible, and highlight the preventive measures taken to control these risks.</Pgraph><Pgraph><Mark1>Methods:</Mark1> A cross-sectional questionnaire-based survey of the prevalence of nosocomial infections in all intensive care units in three university hospital centers, including all patients hospitalized for at least 24 hours. </Pgraph><Pgraph><Mark1>Results:</Mark1> Among the 50 patients included, 30&#37; had a nosocomial infection, the most common of which was pneumonia. Of the 18 bacteria species isolated in 15 patients, 66.7&#37; were MDRO. The most frequently isolated species was <Mark2>Acinetobacter baumannii</Mark2> (44.4&#37;), with a resistance rate of 100&#37; against imepenem.</Pgraph><Pgraph><Mark1>Conclusion:</Mark1> The survey identified the frequency, risk factors and microorganisms responsible for nosocomial infections. This approach helped to guide preventive measures and prioritize efforts, making it a pragmatic and appropriate solution for enhancing the efforts against these infections in contexts where resources are limited.</Pgraph></Abstract>
    <TextBlock name="Introduction" linked="yes">
      <MainHeadline>Introduction</MainHeadline><Pgraph>Healthcare-associated infections (HAIs) are recognized worldwide as a public health problem, and are responsible for a significant increase in mortality, morbidity, and patient care costs <TextLink reference="1"></TextLink>, <TextLink reference="2"></TextLink>. Their frequency and severity are particularly high in intensive care units (ICUs) due to the pathologies presented by patients, associated comorbidities, and the density of invasive interventions <TextLink reference="3"></TextLink>, <TextLink reference="4"></TextLink>. Although ICUs generally account for only a small proportion of hospital beds, they are considered to be a significant reservoir of multidrug-resistant organisms (MDRO) and a place where healthcare-associated infections (HAIs) are very common <TextLink reference="5"></TextLink>, <TextLink reference="6"></TextLink>. The prevalence is four to five times higher in intensive care and resuscitation units compared to other healthcare sectors, and is estimated at 22.4&#37; in a French study <TextLink reference="7"></TextLink>, <TextLink reference="8"></TextLink>, <TextLink reference="9"></TextLink>, <TextLink reference="10"></TextLink>.</Pgraph><Pgraph>Among preventive measures, prevalence studies are a simple, quick, and inexpensive way to rapidly assess the extent of the problem, particularly in developing countries where resources are often limited <TextLink reference="11"></TextLink>, <TextLink reference="12"></TextLink>. Regular prevalence surveys are a valuable tool for monitoring changes in infection rates over time, enabling comparisons between different units within the institution <TextLink reference="13"></TextLink>, <TextLink reference="14"></TextLink>. When conducted at the hospital level, this approach also helps to raise awareness among healthcare workers (HCWs) about the challenges of HAIs and to increase the visibility of the infection control team, particularly when launching a prevention and control program. This approach also facilitates an initial assessment of the problems encountered in each unit, taking into account all types of infections and the diversity of patients. It thus makes it possible to target interventions more effectively and define priorities for treatment <TextLink reference="15"></TextLink>, <TextLink reference="16"></TextLink>.</Pgraph><Pgraph>The aim of this study is to estimate the prevalence of hospital-acquired infections (HAIs) in ICUs, identify the associated risk factors, determine the microorganisms responsible according to anatomical site, and highlight the efforts and actions taken by the infection prevention and control team in managing infection risk in ICUs.</Pgraph></TextBlock>
    <TextBlock name="Materials and methods" linked="yes">
      <MainHeadline>Materials and methods</MainHeadline><SubHeadline>Study design and setting </SubHeadline><Pgraph>A cross-sectional survey of the prevalence of HAIs in all ICUs of three hospitals belonging to a university hospital center in Morocco was conducted in 2024.</Pgraph><SubHeadline>Study population </SubHeadline><Pgraph>The study included all patients hospitalized for at least 24 hours in one of the ICUs and who were present on the day of the survey. Newborns less than two days old were excluded.</Pgraph><SubHeadline>Data collection </SubHeadline><Pgraph>The criteria for defining HAI were based on the WHO definitions <TextLink reference="17"></TextLink>. The data were collected using a questionnaire by doctors and nurses who had received training prior to the day of the survey.</Pgraph><Pgraph>The data were collected from medical records with the support of the attending doctor and nurse. The diagnosis of HAI was made by the investigator and confirmed and documented in collaboration with the doctors in the department.</Pgraph><Pgraph>Statistical analysis was performed using SPSS v. 16 with a significance threshold set at 5&#37;. It consisted of descriptive, bivariate, and multivariate analyses.</Pgraph><SubHeadline>Variables </SubHeadline><Pgraph>The questionnaire consisted of two sections. The first section included general information about the patients (age, gender, length of stay, immunosuppression, ASA score, presence of an invasive medical device, surgical procedure, etc.).The second section was intended only for patients who had an HAI (site of infection, isolated pathogens, etc.).</Pgraph><SubHeadline>Ethical considerations </SubHeadline><Pgraph>Anonymity and confidentiality were respected. Patients were identified using a hospitalization number in order to collect the results of bacteriological diagnostics. The study was approved by the institution&#39;s ethics committee, file no. 04&#47;2025.</Pgraph></TextBlock>
    <TextBlock name="Results" linked="yes">
      <MainHeadline>Results</MainHeadline><SubHeadline>Characteristics of the study population </SubHeadline><Pgraph>The survey involved 50 patients who were hospitalized on the day of the survey for at least 24 hours in intensive care. The study population consisted of 19 (41.3&#37;) female patients and 27 (58.7&#37;) male patients (44.7&#37;). The 45- to 59-year age group represented the largest proportion at over 26&#37;. Interdepartmental transfers from other hospital wards accounted for 44.0&#37; of ICU admissions, whereas direct admissions were less frequent. Among the patients hospitalized on the day of the survey, 71.4&#37; did not have underlying immunodeficiency. More than half of the patients for whom the ASA score was specified had a score &#8805;3; no patients had a score of 5. Among the 50 patients whose date of hospitalisation was specified, 21 (75.6&#37;) were hospitalized for &#60;3 days, 14 (28.0&#37;) had been hospitalized for &#8805;12 days. The average hospital stay was 10.7 days (&#177;12.2). Diagnoses upon admission were medical (64&#37;), emergency surgery 12&#37;, other 12&#37;.</Pgraph><SubHeadline>Invasive devices </SubHeadline><Pgraph>All patients had at least one invasive device, and 92&#37; had two or more devices. Half of the patients (50&#37;) were mechanically ventilated (further details in Table 1 <ImgLink imgNo="1" imgType="table" />).</Pgraph><SubHeadline>Anti-infectives </SubHeadline><Pgraph>78&#37; were prescribed anti-infective treatment (Table 2 <ImgLink imgNo="2" imgType="table" />). </Pgraph><SubHeadline>Nosocomial infections </SubHeadline><Pgraph>15 patients (30.0&#37;) developed a nosocomial infection on different anatomical site (Table 3 <ImgLink imgNo="3" imgType="table" />). </Pgraph><SubHeadline>Bacterial etiology of nosocomial infections </SubHeadline><Pgraph><Mark2>Acinetobacter (A.) baumannii</Mark2> was the most common pathogen, and all isolates were resistant to imipenem (Table 4 <ImgLink imgNo="4" imgType="table" />). </Pgraph></TextBlock>
    <TextBlock name="Discussion" linked="yes">
      <MainHeadline>Discussion</MainHeadline><Pgraph>The prevalence of HAIs in our ICUs (30&#37;) is consistent with findings of studies conducted in sever al countries, where reported prevalence ranged from 3.5&#37; in Iran <TextLink reference="18"></TextLink>, 48.7&#37; in Turkey <TextLink reference="19"></TextLink>, 13&#37; in Serbia <TextLink reference="20"></TextLink>&#91;20&#93;, 43&#37; in Australia. Higher prevalence rates of up to 60&#37; have been reported in Asia and the Middle East <TextLink reference="21"></TextLink>. Similarly, the EPIC (European Prevalence of Infection in Intensive Care) study reported a prevalence of 44.8&#37; <TextLink reference="22"></TextLink>. The differences can be explained by variations in the study periods, as well as by improvements in working conditions and healthcare practices <TextLink reference="22"></TextLink>, <TextLink reference="23"></TextLink>. In addition, the impact of HAI control and surveillance programs plays a key role. According to the latest World Health Organization (WHO) global report on infection prevention and control (2022), well-orchestrated infection control programs can reduce the incidence of nosocomial infections up to 70&#37; <TextLink reference="24"></TextLink>.</Pgraph><Pgraph>On the day of the survey, all patients in ICUs had at least one invasive device, which are the main cause of HAIs, particularly when handling and hygiene rules are not strictly followed <TextLink reference="25"></TextLink>, <TextLink reference="26"></TextLink>. In addition, HAIs associated with invasive devices affect between 24.3&#37; and 27.6&#37; of patients in ICUs, demonstrating their significant impact on the risk of infection in intensive care <TextLink reference="27"></TextLink>.</Pgraph><Pgraph>Ventilator-associated pneumonia (VAP) was the most common (18&#37;), followed by catheter-related infections and bacteraemia. The most frequent sites of infection were consistent with those reported in the literature <TextLink reference="28"></TextLink>, <TextLink reference="29"></TextLink>. VAP is the major factor in the emergence of nosocomial pneumonia, and all studies on this subject show that the number of these infections increases with the duration of ventilation <TextLink reference="30"></TextLink>. A retrospective study (567 patients) showed that the risk of developing nosocomial pneumonia increases by 1&#37; for each additional day of ventilation <TextLink reference="31"></TextLink>. Several studies have also shown that the risk of developing pneumonia acquired under mechanical ventilation is highest between the 8th and 10th day of ventilation <TextLink reference="32"></TextLink>.</Pgraph><Pgraph><Mark2>A. baumannii</Mark2>, the main bacterium isolated in this study, is known as an opportunistic pathogen frequently involved in outbreaks in ICUs and are often associated with contamination of ventilation and respiratory support equipment <TextLink reference="33"></TextLink>, <TextLink reference="34"></TextLink>. In a large international study, Acinetobacter species were responsible for an average of 8.8&#37; of Gram-negative infections in ICUs on all continents, and for more than 19&#37; in Asian ICUs <TextLink reference="35"></TextLink>.</Pgraph><Pgraph>On the day of the survey, 78&#37; of patients received at least one anti-infective agent. Penems were the most commonly prescribed anti-infective agents (48.7&#37;). The increased prescription of carbapenem in recent years may have contributed to the rising incidence of extended-spectrum &#223;-lactamase (ESBL)-producing Enterobacteriaceae and high-level cephalosporinase-producing strains.  <TextLink reference="36"></TextLink>, <TextLink reference="37"></TextLink>, <TextLink reference="38"></TextLink>.</Pgraph><Pgraph>Following this investigation, a prevention program was implemented in all ICUs at the university hospital. Recent studies <TextLink reference="39"></TextLink>, <TextLink reference="40"></TextLink> have shown that an infection control program based on practical and targeted interventions can significantly improve the quality of care and reduce HAIs. This system is based on three main areas: monitoring HAIs (surveillance), promoting standard precautions, and strengthening healthcare workers&#39; skills in hospital hygiene, accompanied by recommendations for controlling the risk of infection in intensive care units. Surveillance makes it possible to quickly identify any increase or change in infections while also assessing the effectiveness of preventive measures <TextLink reference="41"></TextLink>, <TextLink reference="42"></TextLink>. In the present study, surveillance was implemented by two hygienists in close collaboration with the institution&#39;s hygiene team, according to a validated and approved internal procedure.</Pgraph><Pgraph>The second action was the development of a guide to preventing infection risk in intensive care. The idea arose after evaluating the results of the survey. HCWs are confronted daily with repetitive, increasingly complex, and varied care situations in units considered to be a significant reservoir of MDRO in a place where HAIs are very common. The guide takes the form of technical data sheets on hospital hygiene, and the main topics covered include standard and additional precautions, disinfecting cleaning equipment, managing an epidemic, and controlling the spread of MDRO. The main beneficiaries were medical and nursing staff, as well as students. </Pgraph><Pgraph>The third step was simultaneously conducted to improve the use of antibiotics by organizing a masterclass in antibiotic therapy for healthcare staff. The aim was to rationalize the use of antibiotics in intensive care, given that controlling the spread of MDRO and the proper use of antibiotics are the subject of numerous current recommendations.</Pgraph><SubHeadline>Limitations</SubHeadline><Pgraph>A cross-sectional study only provides a snapshot of the situation. Nevertheless, these surveys are cost-effective and allow a large amount of information to be collected in a short period of time compared to incidence studies. Furthermore, inter-observer variability in the interpretation of infection criteria may affect the accuracy of the results. To limit this bias, standardized training was provided to assessors to harmonize the application of diagnostic criteria, and a precise protocol was put in place to ensure consistency of observations during each visit.</Pgraph></TextBlock>
    <TextBlock name="Conclusions" linked="yes">
      <MainHeadline>Conclusions</MainHeadline><Pgraph>This prevalence survey contributes to efforts combating HAIs in intensive care, and can help improve the quality of care, reduce the prevalence of nosocomial infections, and ensure safer and more effective care for the patients. It also identifies areas for improvement in order to optimise infection prevention and management in ICUs.</Pgraph></TextBlock>
    <TextBlock name="Notes" linked="yes">
      <MainHeadline>Notes</MainHeadline><SubHeadline>Competing interests</SubHeadline><Pgraph>The authors declare that they have no competing interests.</Pgraph><SubHeadline>Ethical approval</SubHeadline><Pgraph>The study was approved by the institution&#39;s ethics committee, file no. 04&#47;2025.</Pgraph><SubHeadline>Funding</SubHeadline><Pgraph>None.</Pgraph><SubHeadline>Authors&#8217; ORCIDs</SubHeadline><Pgraph><UnorderedList><ListItem level="1">Arai M: <Hyperlink href="https:&#47;&#47;orcid.org&#47;0000-0002-4936-2403">https:&#47;&#47;orcid.org&#47;0000-0002-4936-2403</Hyperlink></ListItem><ListItem level="1">Ouhadous M: <Hyperlink href="https:&#47;&#47;orcid.org&#47;0000-0001-9790-7140">https:&#47;&#47;orcid.org&#47;0000-0001-9790-7140</Hyperlink></ListItem><ListItem level="1">Lajane H: <Hyperlink href="https:&#47;&#47;orcid.org&#47;0000-0001-6320-4949">https:&#47;&#47;orcid.org&#47;0000-0001-6320-4949</Hyperlink></ListItem><ListItem level="1">Gouifrane R: <Hyperlink href="https:&#47;&#47;orcid.org&#47;0000-0003-0810-6275">https:&#47;&#47;orcid.org&#47;0000-0003-0810-6275</Hyperlink> </ListItem><ListItem level="1">Salih S: <Hyperlink href="https:&#47;&#47;orcid.org&#47;0009-0004-5721-8120">https:&#47;&#47;orcid.org&#47;0009-0004-5721-8120</Hyperlink></ListItem><ListItem level="1">Abidi O: <Hyperlink href="https:&#47;&#47;orcid.org&#47;0000-0002-1105-4798">https:&#47;&#47;orcid.org&#47;0000-0002-1105-4798</Hyperlink></ListItem><ListItem level="1">Khaleq K : <Hyperlink href="https:&#47;&#47;orcid.org&#47;0009-0004-0755-162X">https:&#47;&#47;orcid.org&#47;0009-0004-0755-162X</Hyperlink></ListItem></UnorderedList></Pgraph></TextBlock>
    <References linked="yes">
      <Reference refNo="1">
        <RefAuthor>Raoofi S</RefAuthor>
        <RefAuthor>Pashazadeh Kan F</RefAuthor>
        <RefAuthor>Rafiei S</RefAuthor>
        <RefAuthor>Hosseinipalangi Z</RefAuthor>
        <RefAuthor>Noorani Mejareh Z</RefAuthor>
        <RefAuthor>Khani S</RefAuthor>
        <RefAuthor>Abdollahi B</RefAuthor>
        <RefAuthor>Seyghalani Talab F</RefAuthor>
        <RefAuthor>Sanaei M</RefAuthor>
        <RefAuthor>Zarabi F</RefAuthor>
        <RefAuthor>Dolati Y</RefAuthor>
        <RefAuthor>Ahmadi N</RefAuthor>
        <RefAuthor>Raoofi N</RefAuthor>
        <RefAuthor>Sarhadi Y</RefAuthor>
        <RefAuthor>Masoumi M</RefAuthor>
        <RefAuthor>Sadat Hosseini B</RefAuthor>
        <RefAuthor>Vali N</RefAuthor>
        <RefAuthor>Gholamali N</RefAuthor>
        <RefAuthor>Asadi S</RefAuthor>
        <RefAuthor>Ahmadi S</RefAuthor>
        <RefAuthor>Ahmadi B</RefAuthor>
        <RefAuthor>Beiramy Chomalu Z</RefAuthor>
        <RefAuthor>Asadollahi E</RefAuthor>
        <RefAuthor>Rajabi M</RefAuthor>
        <RefAuthor>Gharagozloo D</RefAuthor>
        <RefAuthor>Nejatifar Z</RefAuthor>
        <RefAuthor>Soheylirad R</RefAuthor>
        <RefAuthor>Jalali S</RefAuthor>
        <RefAuthor>Aghajani F</RefAuthor>
        <RefAuthor>Navidriahy M</RefAuthor>
        <RefAuthor>Deylami S</RefAuthor>
        <RefAuthor>Nasiri M</RefAuthor>
        <RefAuthor>Zareei M</RefAuthor>
        <RefAuthor>Golmohammadi Z</RefAuthor>
        <RefAuthor>Shabani H</RefAuthor>
        <RefAuthor>Torabi F</RefAuthor>
        <RefAuthor>Shabaninejad H</RefAuthor>
        <RefAuthor>Nemati A</RefAuthor>
        <RefAuthor>Amerzadeh M</RefAuthor>
        <RefAuthor>Aryankhesal A</RefAuthor>
        <RefAuthor>Ghashghaee A</RefAuthor>
        <RefTitle>Global prevalence of nosocomial infection: A systematic review and meta-analysis</RefTitle>
        <RefYear>2023</RefYear>
        <RefJournal>PLoS One</RefJournal>
        <RefPage>e0274248</RefPage>
        <RefTotal>Raoofi S, Pashazadeh Kan F, Rafiei S, Hosseinipalangi Z, Noorani Mejareh Z, Khani S, Abdollahi B, Seyghalani Talab F, Sanaei M, Zarabi F, Dolati Y, Ahmadi N, Raoofi N, Sarhadi Y, Masoumi M, Sadat Hosseini B, Vali N, Gholamali N, Asadi S, Ahmadi S, Ahmadi B, Beiramy Chomalu Z, Asadollahi E, Rajabi M, Gharagozloo D, Nejatifar Z, Soheylirad R, Jalali S, Aghajani F, Navidriahy M, Deylami S, Nasiri M, Zareei M, Golmohammadi Z, Shabani H, Torabi F, Shabaninejad H, Nemati A, Amerzadeh M, Aryankhesal A, Ghashghaee A. Global prevalence of nosocomial infection: A systematic review and meta-analysis. PLoS One. 2023;18(1):e0274248. DOI: 10.1371&#47;journal.pone.0274248</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1371&#47;journal.pone.0274248</RefLink>
      </Reference>
      <Reference refNo="2">
        <RefAuthor>Tao L</RefAuthor>
        <RefAuthor>Hu B</RefAuthor>
        <RefAuthor>Rosenthal VD</RefAuthor>
        <RefAuthor>Gao X</RefAuthor>
        <RefAuthor>He L</RefAuthor>
        <RefTitle>Device-associated infection rates in 398 intensive care units in Shanghai, China: International Nosocomial Infection Control Consortium (INICC) findings</RefTitle>
        <RefYear>2011</RefYear>
        <RefJournal>Int J Infect Dis</RefJournal>
        <RefPage>e774-80</RefPage>
        <RefTotal>Tao L, Hu B, Rosenthal VD, Gao X, He L. Device-associated infection rates in 398 intensive care units in Shanghai, China: International Nosocomial Infection Control Consortium (INICC) findings. Int J Infect Dis. 2011 Nov;15(11):e774-80. DOI: 10.1016&#47;j.ijid.2011.06.009</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;j.ijid.2011.06.009</RefLink>
      </Reference>
      <Reference refNo="3">
        <RefAuthor>Merzougui L</RefAuthor>
        <RefAuthor>Barhoumi T</RefAuthor>
        <RefAuthor>Guizani T</RefAuthor>
        <RefAuthor>Barhoumi H</RefAuthor>
        <RefAuthor>Hannachi H</RefAuthor>
        <RefAuthor>Turki E</RefAuthor>
        <RefAuthor></RefAuthor>
        <RefTitle>Les infections nosocomiales en milieu de r&#233;animation: incidence annuelle et aspects cliniques au Service de R&#233;animation Polyvalente, Kairouan, Tunisie, 2014</RefTitle>
        <RefYear>2018</RefYear>
        <RefJournal>Pan Afr Med J</RefJournal>
        <RefPage>143</RefPage>
        <RefTotal>Merzougui L, Barhoumi T, Guizani T, Barhoumi H, Hannachi H, Turki E, et al. Les infections nosocomiales en milieu de r&#233;animation: incidence annuelle et aspects cliniques au Service de R&#233;animation Polyvalente, Kairouan, Tunisie, 2014. Pan Afr Med J. 2018;30:143.. DOI: 10.11604&#47;pamj.2018.30.143.13824</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.11604&#47;pamj.2018.30.143.13824</RefLink>
      </Reference>
      <Reference refNo="4">
        <RefAuthor>Zolfaghari M</RefAuthor>
        <RefAuthor>Seifi A</RefAuthor>
        <RefAuthor>Jaafaripooyan E</RefAuthor>
        <RefAuthor>Jahangard-Rafsanjani Z</RefAuthor>
        <RefAuthor>Afhami S</RefAuthor>
        <RefAuthor>Mohammadi M</RefAuthor>
        <RefAuthor></RefAuthor>
        <RefTitle>Burden of nosocomial infections in intensive care units: Cost of antibiotics, the extra length of stay and mortality rate</RefTitle>
        <RefYear>2024</RefYear>
        <RefJournal>Caspian J Intern Med</RefJournal>
        <RefPage>478-83</RefPage>
        <RefTotal>Zolfaghari M, Seifi A, Jaafaripooyan E, Jahangard-Rafsanjani Z, Afhami S, Mohammadi M, et al. Burden of nosocomial infections in intensive care units: Cost of antibiotics, the extra length of stay and mortality rate. Caspian J Intern Med. 2024 Summer; 15(3):478-83. DOI: 10.22088&#47;cjim.15.3.478</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.22088&#47;cjim.15.3.478</RefLink>
      </Reference>
      <Reference refNo="5">
        <RefAuthor>Wo&#378;niak A</RefAuthor>
        <RefAuthor>Janc J</RefAuthor>
        <RefAuthor>&#321;ysenko L</RefAuthor>
        <RefAuthor>Le&#347;nik P</RefAuthor>
        <RefAuthor>S&#322;abisz N</RefAuthor>
        <RefAuthor>Oleksy-Wawrzyniak M</RefAuthor>
        <RefAuthor>Uchmanowicz I</RefAuthor>
        <RefTitle>How to Defeat Multidrug-Resistant Bacteria in Intensive Care Units. A Lesson from the COVID-19 Pandemic. Prevention, Reservoirs, and Implications for Clinical Practice</RefTitle>
        <RefYear>2024</RefYear>
        <RefJournal>Int J Med Sci</RefJournal>
        <RefPage>530-539</RefPage>
        <RefTotal>Wo&#378;niak A, Janc J, &#321;ysenko L, Le&#347;nik P, S&#322;abisz N, Oleksy-Wawrzyniak M, Uchmanowicz I. How to Defeat Multidrug-Resistant Bacteria in Intensive Care Units. A Lesson from the COVID-19 Pandemic. Prevention, Reservoirs, and Implications for Clinical Practice. Int J Med Sci. 2024;21(3):530-539. DOI: 10.7150&#47;ijms.88519</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.7150&#47;ijms.88519</RefLink>
      </Reference>
      <Reference refNo="6">
        <RefAuthor>Litwin A</RefAuthor>
        <RefAuthor>Fedorowicz O</RefAuthor>
        <RefAuthor>Duszynska W</RefAuthor>
        <RefTitle>Characteristics of Microbial Factors of Healthcare-Associated Infections Including Multidrug-Resistant Pathogens and Antibiotic Consumption at the University Intensive Care Unit in Poland in the Years 2011-2018</RefTitle>
        <RefYear>2020</RefYear>
        <RefJournal>Int J Environ Res Public Health</RefJournal>
        <RefPage></RefPage>
        <RefTotal>Litwin A, Fedorowicz O, Duszynska W. Characteristics of Microbial Factors of Healthcare-Associated Infections Including Multidrug-Resistant Pathogens and Antibiotic Consumption at the University Intensive Care Unit in Poland in the Years 2011-2018. Int J Environ Res Public Health. 2020 Sep;17(19). DOI: 10.3390&#47;ijerph17196943</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.3390&#47;ijerph17196943</RefLink>
      </Reference>
      <Reference refNo="7">
        <RefAuthor>Aiesh BM</RefAuthor>
        <RefAuthor>Qashou R</RefAuthor>
        <RefAuthor>Shemmessian G</RefAuthor>
        <RefAuthor>Swaileh MW</RefAuthor>
        <RefAuthor>Abutaha SA</RefAuthor>
        <RefAuthor>Sabateen A</RefAuthor>
        <RefAuthor>Barqawi AK</RefAuthor>
        <RefAuthor>AbuTaha A</RefAuthor>
        <RefAuthor>Zyoud SH</RefAuthor>
        <RefTitle>Nosocomial infections in the surgical intensive care unit: an observational retrospective study from a large tertiary hospital in Palestine</RefTitle>
        <RefYear>2023</RefYear>
        <RefJournal>BMC Infect Dis</RefJournal>
        <RefPage>686</RefPage>
        <RefTotal>Aiesh BM, Qashou R, Shemmessian G, Swaileh MW, Abutaha SA, Sabateen A, Barqawi AK, AbuTaha A, Zyoud SH. Nosocomial infections in the surgical intensive care unit: an observational retrospective study from a large tertiary hospital in Palestine. BMC Infect Dis. 2023 Oct;23(1):686. DOI: 10.1186&#47;s12879-023-08677-z</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1186&#47;s12879-023-08677-z</RefLink>
      </Reference>
      <Reference refNo="8">
        <RefAuthor>Zaragoza R</RefAuthor>
        <RefAuthor>Ram&#237;rez P</RefAuthor>
        <RefAuthor>L&#243;pez-Pueyo MJ</RefAuthor>
        <RefTitle>Infecci&#243;n nosocomial en las unidades de cuidados intensivos</RefTitle>
        <RefYear>2014</RefYear>
        <RefJournal>Enferm Infecc Microbiol Clin</RefJournal>
        <RefPage>320-7</RefPage>
        <RefTotal>Zaragoza R, Ram&#237;rez P, L&#243;pez-Pueyo MJ. Infecci&#243;n nosocomial en las unidades de cuidados intensivos &#91;Nosocomial infections in intensive care units&#93;. Enferm Infecc Microbiol Clin. 2014 May;32(5):320-7. DOI: 10.1016&#47;j.eimc.2014.02.006</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;j.eimc.2014.02.006</RefLink>
      </Reference>
      <Reference refNo="9">
        <RefAuthor>Migliara G</RefAuthor>
        <RefAuthor>Di Paolo C</RefAuthor>
        <RefAuthor>Barbato D</RefAuthor>
        <RefTitle>Multimodal surveillance of healthcare associated infections in an intensive care unit of a large teaching hospital</RefTitle>
        <RefYear>2019</RefYear>
        <RefJournal>Ann Ig</RefJournal>
        <RefPage>399-413</RefPage>
        <RefTotal>Migliara G, Di Paolo C, Barbato D. Multimodal surveillance of healthcare associated infections in an intensive care unit of a large teaching hospital. Ann Ig. 2019 Sep-Oct; 31(5):399-413. DOI: 10.7416&#47;ai.2019.2302</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.7416&#47;ai.2019.2302</RefLink>
      </Reference>
      <Reference refNo="10">
        <RefAuthor>Ko&#322;pa M</RefAuthor>
        <RefAuthor>Wa&#322;aszek M</RefAuthor>
        <RefAuthor>Gniadek A</RefAuthor>
        <RefAuthor>Wolak Z</RefAuthor>
        <RefAuthor>Dobro&#347; W</RefAuthor>
        <RefTitle>Incidence, Microbiological Profile and Risk Factors of Healthcare-Associated Infections in Intensive Care Units: A 10 Year Observation in a Provincial Hospital in Southern Poland</RefTitle>
        <RefYear>2018</RefYear>
        <RefJournal>Int J Environ Res Public Health</RefJournal>
        <RefPage></RefPage>
        <RefTotal>Ko&#322;pa M, Wa&#322;aszek M, Gniadek A, Wolak Z, Dobro&#347; W. Incidence, Microbiological Profile and Risk Factors of Healthcare-Associated Infections in Intensive Care Units: A 10 Year Observation in a Provincial Hospital in Southern Poland. Int J Environ Res Public Health. 2018 Jan;15(1). DOI: 10.3390&#47;ijerph15010112</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.3390&#47;ijerph15010112</RefLink>
      </Reference>
      <Reference refNo="11">
        <RefAuthor>Yu T</RefAuthor>
        <RefAuthor>Zhang X</RefAuthor>
        <RefAuthor>Wang Q</RefAuthor>
        <RefAuthor>Zheng F</RefAuthor>
        <RefAuthor>Wang L</RefAuthor>
        <RefTitle>Communication openness and nosocomial infection reporting: the mediating role of team cohesion</RefTitle>
        <RefYear>2022</RefYear>
        <RefJournal>BMC Health Serv Res</RefJournal>
        <RefPage>1416</RefPage>
        <RefTotal>Yu T, Zhang X, Wang Q, Zheng F, Wang L. Communication openness and nosocomial infection reporting: the mediating role of team cohesion. BMC Health Serv Res. 2022 Nov;22(1):1416. DOI: 10.1186&#47;s12913-022-08646-3</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1186&#47;s12913-022-08646-3</RefLink>
      </Reference>
      <Reference refNo="12">
        <RefAuthor>Gastmeier P</RefAuthor>
        <RefAuthor>Geffers C</RefAuthor>
        <RefAuthor>Brandt C</RefAuthor>
        <RefAuthor>Zuschneid I</RefAuthor>
        <RefAuthor>Sohr D</RefAuthor>
        <RefAuthor>Schwab F</RefAuthor>
        <RefAuthor>Behnke M</RefAuthor>
        <RefAuthor>Daschner F</RefAuthor>
        <RefAuthor>R&#252;den H</RefAuthor>
        <RefTitle>Effectiveness of a nationwide nosocomial infection surveillance system for reducing nosocomial infections</RefTitle>
        <RefYear>2006</RefYear>
        <RefJournal>J Hosp Infect</RefJournal>
        <RefPage>16-22</RefPage>
        <RefTotal>Gastmeier P, Geffers C, Brandt C, Zuschneid I, Sohr D, Schwab F, Behnke M, Daschner F, R&#252;den H. Effectiveness of a nationwide nosocomial infection surveillance system for reducing nosocomial infections. J Hosp Infect. 2006 Sep;64(1):16-22. DOI: 10.1016&#47;j.jhin.2006.04.017</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;j.jhin.2006.04.017</RefLink>
      </Reference>
      <Reference refNo="13">
        <RefAuthor>Li Y</RefAuthor>
        <RefAuthor>Cao X</RefAuthor>
        <RefAuthor>Ge H</RefAuthor>
        <RefAuthor>Jiang Y</RefAuthor>
        <RefAuthor>Zhou H</RefAuthor>
        <RefAuthor>Zheng W</RefAuthor>
        <RefTitle>Targeted surveillance of nosocomial infection in intensive care units of 176 hospitals in Jiangsu province, China</RefTitle>
        <RefYear>2018</RefYear>
        <RefJournal>J Hosp Infect</RefJournal>
        <RefPage>36-41</RefPage>
        <RefTotal>Li Y, Cao X, Ge H, Jiang Y, Zhou H, Zheng W. Targeted surveillance of nosocomial infection in intensive care units of 176 hospitals in Jiangsu province, China. J Hosp Infect. 2018 May;99(1):36-41. DOI: 10.1016&#47;j.jhin.2017.10.009</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;j.jhin.2017.10.009</RefLink>
      </Reference>
      <Reference refNo="14">
        <RefAuthor>Mazzeffi M</RefAuthor>
        <RefAuthor>Galvagno S</RefAuthor>
        <RefAuthor>Rock C</RefAuthor>
        <RefTitle>Prevention of Healthcare-associated Infections in Intensive Care Unit Patients</RefTitle>
        <RefYear>2021</RefYear>
        <RefJournal>Anesthesiology</RefJournal>
        <RefPage>1122-1131</RefPage>
        <RefTotal>Mazzeffi M, Galvagno S, Rock C. Prevention of Healthcare-associated Infections in Intensive Care Unit Patients. Anesthesiology. 2021 Dec;135(6):1122-1131. DOI: 10.1097&#47;ALN.0000000000004017</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1097&#47;ALN.0000000000004017</RefLink>
      </Reference>
      <Reference refNo="15">
        <RefAuthor>Abubakar U</RefAuthor>
        <RefTitle>Point-prevalence survey of hospital acquired infections in three acute care hospitals in Northern Nigeria</RefTitle>
        <RefYear>2020</RefYear>
        <RefJournal>Antimicrob Resist Infect Control</RefJournal>
        <RefPage>63</RefPage>
        <RefTotal>Abubakar U. Point-prevalence survey of hospital acquired infections in three acute care hospitals in Northern Nigeria. Antimicrob Resist Infect Control. 2020 May;9(1):63. DOI: 10.1186&#47;s13756-020-00722-9</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1186&#47;s13756-020-00722-9</RefLink>
      </Reference>
      <Reference refNo="16">
        <RefAuthor>Despotovic A</RefAuthor>
        <RefAuthor>Milosevic B</RefAuthor>
        <RefAuthor>Milosevic I</RefAuthor>
        <RefAuthor>Mitrovic N</RefAuthor>
        <RefAuthor>Cirkovic A</RefAuthor>
        <RefAuthor>Jovanovic S</RefAuthor>
        <RefAuthor>Stevanovic G</RefAuthor>
        <RefTitle>Hospital-acquired infections in the adult intensive care unit-Epidemiology, antimicrobial resistance patterns, and risk factors for acquisition and mortality</RefTitle>
        <RefYear>2020</RefYear>
        <RefJournal>Am J Infect Control</RefJournal>
        <RefPage>1211-1215</RefPage>
        <RefTotal>Despotovic A, Milosevic B, Milosevic I, Mitrovic N, Cirkovic A, Jovanovic S, Stevanovic G. Hospital-acquired infections in the adult intensive care unit-Epidemiology, antimicrobial resistance patterns, and risk factors for acquisition and mortality. Am J Infect Control. 2020 Oct;48(10):1211-1215. DOI: 10.1016&#47;j.ajic.2020.01.009</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;j.ajic.2020.01.009</RefLink>
      </Reference>
      <Reference refNo="17">
        <RefAuthor>Ducel G</RefAuthor>
        <RefAuthor>Fabry J</RefAuthor>
        <RefAuthor>Nicolle L</RefAuthor>
        <RefAuthor></RefAuthor>
        <RefTitle></RefTitle>
        <RefYear>2002</RefYear>
        <RefBookTitle>WHO&#47;CDS&#47;CSR&#47;EPH&#47;20021.2 &#8211; Prevention of hospital-acquired infections: A practical guide</RefBookTitle>
        <RefPage></RefPage>
        <RefTotal>Ducel G, Fabry J, Nicolle L, et al. WHO&#47;CDS&#47;CSR&#47;EPH&#47;2002.12 &#8211; Prevention of hospital-acquired infections: A practical guide. 2nd ed. Geneva: World Health Organization; 2002.</RefTotal>
      </Reference>
      <Reference refNo="18">
        <RefAuthor>Golsha R</RefAuthor>
        <RefAuthor>Ashoori N</RefAuthor>
        <RefAuthor>Tajik M</RefAuthor>
        <RefAuthor>Sohrabi A</RefAuthor>
        <RefAuthor>Montazeri M</RefAuthor>
        <RefTitle>Prevalence of nosocomial infections in intensive care units in Shahid Sayyad-E-Shirazi hospital of Gorgan During 2016-2018</RefTitle>
        <RefYear>2020</RefYear>
        <RefJournal>Tabari Biomed Stu Res J</RefJournal>
        <RefPage>48-57</RefPage>
        <RefTotal>Golsha R, Ashoori N, Tajik M, Sohrabi A, Montazeri M. Prevalence of nosocomial infections in intensive care units in Shahid Sayyad-E-Shirazi hospital of Gorgan During 2016-2018. Tabari Biomed Stu Res J. 2020 Jul 29;2(2):48-57. DOI: 10.18502&#47;tbsrj.v2i2.376</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.18502&#47;tbsrj.v2i2.376</RefLink>
      </Reference>
      <Reference refNo="19">
        <RefAuthor>Esen S</RefAuthor>
        <RefAuthor>Leblebicioglu H</RefAuthor>
        <RefTitle>Prevalence of nosocomial infections at intensive care units in Turkey: a multicentre 1-day point prevalence study</RefTitle>
        <RefYear>2004</RefYear>
        <RefJournal>Scand J Infect Dis</RefJournal>
        <RefPage>144-8</RefPage>
        <RefTotal>Esen S, Leblebicioglu H. Prevalence of nosocomial infections at intensive care units in Turkey: a multicentre 1-day point prevalence study. Scand J Infect Dis. 2004;36(2):144-8. DOI: 10.1080&#47;00365540410019156</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1080&#47;00365540410019156</RefLink>
      </Reference>
      <Reference refNo="20">
        <RefAuthor>Spahija G</RefAuthor>
        <RefAuthor>Raka L</RefAuthor>
        <RefAuthor>Mulliqi G</RefAuthor>
        <RefAuthor>Spahija N</RefAuthor>
        <RefAuthor>Bukoshi Z</RefAuthor>
        <RefAuthor>Hoxha F</RefAuthor>
        <RefAuthor>Krasniqi A</RefAuthor>
        <RefTitle>Prevalence of nosocomial infections in adult intensive care units at a Kosova teaching hospital</RefTitle>
        <RefYear>2008</RefYear>
        <RefJournal>Infect Control Hosp Epidemiol</RefJournal>
        <RefPage>475</RefPage>
        <RefTotal>Spahija G, Raka L, Mulliqi G, Spahija N, Bukoshi Z, Hoxha F, Krasniqi A. Prevalence of nosocomial infections in adult intensive care units at a Kosova teaching hospital. Infect Control Hosp Epidemiol. 2008 May;29(5):475. DOI: 10.1086&#47;533480</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1086&#47;533480</RefLink>
      </Reference>
      <Reference refNo="21">
        <RefAuthor>Vincent JL</RefAuthor>
        <RefAuthor>Sakr Y</RefAuthor>
        <RefAuthor>Singer M</RefAuthor>
        <RefAuthor>Martin-Loeches I</RefAuthor>
        <RefAuthor>Machado FR</RefAuthor>
        <RefAuthor>Marshall JC</RefAuthor>
        <RefAuthor>Finfer S</RefAuthor>
        <RefAuthor>Pelosi P</RefAuthor>
        <RefAuthor>Brazzi L</RefAuthor>
        <RefAuthor>Aditianingsih D</RefAuthor>
        <RefAuthor>Timsit JF</RefAuthor>
        <RefAuthor>Du B</RefAuthor>
        <RefAuthor>Wittebole X</RefAuthor>
        <RefAuthor>M&#225;ca J</RefAuthor>
        <RefAuthor>Kannan S</RefAuthor>
        <RefAuthor>Gorordo-Delsol LA</RefAuthor>
        <RefAuthor>De Waele JJ</RefAuthor>
        <RefAuthor>Mehta Y</RefAuthor>
        <RefAuthor>Bonten MJM</RefAuthor>
        <RefAuthor>Khanna AK</RefAuthor>
        <RefAuthor>Kollef M</RefAuthor>
        <RefAuthor>Human M</RefAuthor>
        <RefAuthor>Angus DC</RefAuthor>
        <RefAuthor> EPIC III Investigators</RefAuthor>
        <RefTitle>Prevalence and Outcomes of Infection Among Patients in Intensive Care Units in 2017</RefTitle>
        <RefYear>2020</RefYear>
        <RefJournal>JAMA</RefJournal>
        <RefPage>1478-1487</RefPage>
        <RefTotal>Vincent JL, Sakr Y, Singer M, Martin-Loeches I, Machado FR, Marshall JC, Finfer S, Pelosi P, Brazzi L, Aditianingsih D, Timsit JF, Du B, Wittebole X, M&#225;ca J, Kannan S, Gorordo-Delsol LA, De Waele JJ, Mehta Y, Bonten MJM, Khanna AK, Kollef M, Human M, Angus DC; EPIC III Investigators. Prevalence and Outcomes of Infection Among Patients in Intensive Care Units in 2017. JAMA. 2020 Apr;323(15):1478-1487. DOI: 10.1001&#47;jama.2020.2717</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1001&#47;jama.2020.2717</RefLink>
      </Reference>
      <Reference refNo="22">
        <RefAuthor>Haque M</RefAuthor>
        <RefAuthor>McKimm J</RefAuthor>
        <RefAuthor>Sartelli M</RefAuthor>
        <RefAuthor>Dhingra S</RefAuthor>
        <RefAuthor>Labricciosa FM</RefAuthor>
        <RefAuthor>Islam S</RefAuthor>
        <RefAuthor>Jahan D</RefAuthor>
        <RefAuthor>Nusrat T</RefAuthor>
        <RefAuthor>Chowdhury TS</RefAuthor>
        <RefAuthor>Coccolini F</RefAuthor>
        <RefAuthor>Iskandar K</RefAuthor>
        <RefAuthor>Catena F</RefAuthor>
        <RefAuthor>Charan J</RefAuthor>
        <RefTitle>Strategies to Prevent Healthcare-Associated Infections: A Narrative Overview</RefTitle>
        <RefYear>2020</RefYear>
        <RefJournal>Risk Manag Healthc Policy</RefJournal>
        <RefPage>1765-1780</RefPage>
        <RefTotal>Haque M, McKimm J, Sartelli M, Dhingra S, Labricciosa FM, Islam S, Jahan D, Nusrat T, Chowdhury TS, Coccolini F, Iskandar K, Catena F, Charan J. Strategies to Prevent Healthcare-Associated Infections: A Narrative Overview. Risk Manag Healthc Policy. 2020;13:1765-1780. DOI: 10.2147&#47;RMHP.S269315</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.2147&#47;RMHP.S269315</RefLink>
      </Reference>
      <Reference refNo="23">
        <RefAuthor>Friedrich AW</RefAuthor>
        <RefTitle>Control of hospital acquired infections and antimicrobial resistance in Europe: the way to go</RefTitle>
        <RefYear>2019</RefYear>
        <RefJournal>Wien Med Wochenschr</RefJournal>
        <RefPage>25-30</RefPage>
        <RefTotal>Friedrich AW. Control of hospital acquired infections and antimicrobial resistance in Europe: the way to go. Wien Med Wochenschr. 2019 Feb;169(Suppl 1):25-30. DOI: 10.1007&#47;s10354-018-0676-5</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1007&#47;s10354-018-0676-5</RefLink>
      </Reference>
      <Reference refNo="24">
        <RefAuthor>World Health Organization</RefAuthor>
        <RefTitle></RefTitle>
        <RefYear>2022</RefYear>
        <RefBookTitle>Global Report on Infection Prevention and Control</RefBookTitle>
        <RefPage></RefPage>
        <RefTotal>World Health Organization. Global Report on Infection Prevention and Control. 1st ed. Geneva: WHO; 2022. Available from: https:&#47;&#47;iris.who.int&#47;bitstream&#47;handle&#47;10665&#47;354489&#47;9789240051164-eng.pdf&#63;sequence&#61;1&#38;isAllowed&#61;y</RefTotal>
        <RefLink>https:&#47;&#47;iris.who.int&#47;bitstream&#47;handle&#47;10665&#47;354489&#47;9789240051164-eng.pdf&#63;sequence&#61;1&#38;isAllowed&#61;y</RefLink>
      </Reference>
      <Reference refNo="25">
        <RefAuthor>AlSaleh E</RefAuthor>
        <RefAuthor>Naik B</RefAuthor>
        <RefAuthor>AlSaleh AM</RefAuthor>
        <RefTitle>Device-associated nosocomial infections in intensive care units at Al-Ahsa hospitals, Saudi Arabia</RefTitle>
        <RefYear>2023</RefYear>
        <RefJournal>Cureus</RefJournal>
        <RefPage>e50187</RefPage>
        <RefTotal>AlSaleh E, Naik B, AlSaleh AM. Device-associated nosocomial infections in intensive care units at Al-Ahsa hospitals, Saudi Arabia. Cureus. 2023 Dec 8; 15 (12)): e50187. DOI: 10.7759&#47;cureus.50187</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.7759&#47;cureus.50187</RefLink>
      </Reference>
      <Reference refNo="26">
        <RefAuthor>Aman S</RefAuthor>
        <RefAuthor>Mittal D</RefAuthor>
        <RefAuthor>Shriwastav S</RefAuthor>
        <RefAuthor>Tuli HS</RefAuthor>
        <RefAuthor>Chauhan S</RefAuthor>
        <RefAuthor>Singh P</RefAuthor>
        <RefAuthor>Sharma S</RefAuthor>
        <RefAuthor>Saini RV</RefAuthor>
        <RefAuthor>Kaur N</RefAuthor>
        <RefAuthor>Saini AK</RefAuthor>
        <RefTitle>Prevalence of multidrug-resistant strains in device associated nosocomial infection and their in vitro killing by nanocomposites</RefTitle>
        <RefYear>2022</RefYear>
        <RefJournal>Ann Med Surg (Lond)</RefJournal>
        <RefPage>103687</RefPage>
        <RefTotal>Aman S, Mittal D, Shriwastav S, Tuli HS, Chauhan S, Singh P, Sharma S, Saini RV, Kaur N, Saini AK. Prevalence of multidrug-resistant strains in device associated nosocomial infection and their in vitro killing by nanocomposites. Ann Med Surg (Lond). 2022 Jun;78:103687. DOI: 10.1016&#47;j.amsu.2022.103687</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;j.amsu.2022.103687</RefLink>
      </Reference>
      <Reference refNo="27">
        <RefAuthor>Duszynska W</RefAuthor>
        <RefAuthor>Rosenthal VD</RefAuthor>
        <RefAuthor>Szczesny A</RefAuthor>
        <RefAuthor>Zajaczkowska K</RefAuthor>
        <RefAuthor>Fulek M</RefAuthor>
        <RefAuthor>Tomaszewski J</RefAuthor>
        <RefTitle>Device associated -health care associated infections monitoring, prevention and cost assessment at intensive care unit of University Hospital in Poland (2015-2017)</RefTitle>
        <RefYear>2020</RefYear>
        <RefJournal>BMC Infect Dis</RefJournal>
        <RefPage>761</RefPage>
        <RefTotal>Duszynska W, Rosenthal VD, Szczesny A, Zajaczkowska K, Fulek M, Tomaszewski J. Device associated -health care associated infections monitoring, prevention and cost assessment at intensive care unit of University Hospital in Poland (2015-2017). BMC Infect Dis. 2020 Oct;20(1):761. DOI: 10.1186&#47;s12879-020-05482-w</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1186&#47;s12879-020-05482-w</RefLink>
      </Reference>
      <Reference refNo="28">
        <RefAuthor>Dasgupta S</RefAuthor>
        <RefAuthor>Das S</RefAuthor>
        <RefAuthor>Chawan NS</RefAuthor>
        <RefAuthor>Hazra A</RefAuthor>
        <RefTitle>Nosocomial infections in the intensive care unit: Incidence, risk factors, outcome and associated pathogens in a public tertiary teaching hospital of Eastern India</RefTitle>
        <RefYear>2015</RefYear>
        <RefJournal>Indian J Crit Care Med</RefJournal>
        <RefPage>14-20</RefPage>
        <RefTotal>Dasgupta S, Das S, Chawan NS, Hazra A. Nosocomial infections in the intensive care unit: Incidence, risk factors, outcome and associated pathogens in a public tertiary teaching hospital of Eastern India. Indian J Crit Care Med. 2015 Jan;19(1):14-20. DOI: 10.4103&#47;0972-5229.148633</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.4103&#47;0972-5229.148633</RefLink>
      </Reference>
      <Reference refNo="29">
        <RefAuthor>Kumar A</RefAuthor>
        <RefAuthor>Chaudhry D</RefAuthor>
        <RefAuthor>Goel N</RefAuthor>
        <RefAuthor>Tanwar S</RefAuthor>
        <RefTitle>Epidemiology of Intensive Care Unit-acquired Infections in a Tertiary Care Hospital of North India</RefTitle>
        <RefYear>2021</RefYear>
        <RefJournal>Indian J Crit Care Med</RefJournal>
        <RefPage>1427-1433</RefPage>
        <RefTotal>Kumar A, Chaudhry D, Goel N, Tanwar S. Epidemiology of Intensive Care Unit-acquired Infections in a Tertiary Care Hospital of North India. Indian J Crit Care Med. 2021 Dec;25(12):1427-1433. DOI: 10.5005&#47;jp-journals-10071-24058</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.5005&#47;jp-journals-10071-24058</RefLink>
      </Reference>
      <Reference refNo="30">
        <RefAuthor>Bougl&#233; A</RefAuthor>
        <RefAuthor>Foucrier A</RefAuthor>
        <RefAuthor>Dupont H</RefAuthor>
        <RefAuthor>Montravers P</RefAuthor>
        <RefAuthor>Ouattara A</RefAuthor>
        <RefAuthor>Kalfon P</RefAuthor>
        <RefAuthor>Squara P</RefAuthor>
        <RefAuthor>Simon T</RefAuthor>
        <RefAuthor>Amour J</RefAuthor>
        <RefAuthor> iDIAPASON study group</RefAuthor>
        <RefTitle>Impact of the duration of antibiotics on clinical events in patients with Pseudomonas aeruginosa ventilator-associated pneumonia: study protocol for a randomized controlled study</RefTitle>
        <RefYear>2017</RefYear>
        <RefJournal>Trials</RefJournal>
        <RefPage>37</RefPage>
        <RefTotal>Bougl&#233; A, Foucrier A, Dupont H, Montravers P, Ouattara A, Kalfon P, Squara P, Simon T, Amour J; iDIAPASON study group. Impact of the duration of antibiotics on clinical events in patients with Pseudomonas aeruginosa ventilator-associated pneumonia: study protocol for a randomized controlled study. Trials. 2017 Jan;18(1):37. DOI: 10.1186&#47;s13063-017-1780-3</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1186&#47;s13063-017-1780-3</RefLink>
      </Reference>
      <Reference refNo="31">
        <RefAuthor>Shimi A</RefAuthor>
        <RefAuthor>Touzani S</RefAuthor>
        <RefAuthor>Elbakouri N</RefAuthor>
        <RefAuthor>Bechri B</RefAuthor>
        <RefAuthor>Derkaoui A</RefAuthor>
        <RefAuthor>Khatouf M</RefAuthor>
        <RefTitle>Les pneumopathies nosocomiales en r&#233;animation de CHU Hassan II de F&#232;s</RefTitle>
        <RefYear>2015</RefYear>
        <RefJournal>Pan Afr Med J</RefJournal>
        <RefPage>285</RefPage>
        <RefTotal>Shimi A, Touzani S, Elbakouri N, Bechri B, Derkaoui A, Khatouf M. Les pneumopathies nosocomiales en r&#233;animation de CHU Hassan II de F&#232;s. Pan Afr Med J. 2015 Nov 23;22:285. DOI: 10.11604&#47;pamj.2015.22.285.7630</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.11604&#47;pamj.2015.22.285.7630</RefLink>
      </Reference>
      <Reference refNo="32">
        <RefAuthor>Kalanuria AA</RefAuthor>
        <RefAuthor>Ziai W</RefAuthor>
        <RefAuthor>Mirski M</RefAuthor>
        <RefTitle>Erratum to: Ventilator-associated pneumonia in the ICU</RefTitle>
        <RefYear>2016</RefYear>
        <RefJournal>Crit Care</RefJournal>
        <RefPage>29</RefPage>
        <RefTotal>Kalanuria AA, Ziai W, Mirski M. Erratum to: Ventilator-associated pneumonia in the ICU. Crit Care. 2016 Jan;20:29. DOI: 10.1186&#47;s13054-016-1206-8</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1186&#47;s13054-016-1206-8</RefLink>
      </Reference>
      <Reference refNo="33">
        <RefAuthor>Huang J</RefAuthor>
        <RefAuthor>Chen EZ</RefAuthor>
        <RefAuthor>Qu HP</RefAuthor>
        <RefAuthor>Mao EQ</RefAuthor>
        <RefAuthor>Zhu ZG</RefAuthor>
        <RefAuthor>Ni YX</RefAuthor>
        <RefAuthor>Han LZ</RefAuthor>
        <RefAuthor>Tang YQ</RefAuthor>
        <RefTitle>Sources of multidrug-resistant Acinetobacter baumannii and its role in respiratory tract colonization and nosocomial pneumonia in intensive care unit patients</RefTitle>
        <RefYear>2013</RefYear>
        <RefJournal>Chin Med J (Engl)</RefJournal>
        <RefPage>1826-31</RefPage>
        <RefTotal>Huang J, Chen EZ, Qu HP, Mao EQ, Zhu ZG, Ni YX, Han LZ, Tang YQ. Sources of multidrug-resistant Acinetobacter baumannii and its role in respiratory tract colonization and nosocomial pneumonia in intensive care unit patients. Chin Med J (Engl). 2013;126(10):1826-31.</RefTotal>
      </Reference>
      <Reference refNo="34">
        <RefAuthor>Cucunawagsih C</RefAuthor>
        <RefAuthor>Wiwing V</RefAuthor>
        <RefAuthor>Lugito NPH</RefAuthor>
        <RefTitle>Antimicrobial susceptibility of multidrug-resistant Acinetobacter baumanii in a teaching hospital: a two-year observation</RefTitle>
        <RefYear>2015</RefYear>
        <RefJournal>Open J Med Microbiol</RefJournal>
        <RefPage>85-9</RefPage>
        <RefTotal>Cucunawagsih C, Wiwing V, Lugito NPH. Antimicrobial susceptibility of multidrug-resistant Acinetobacter baumanii in a teaching hospital: a two-year observation. Open J Med Microbiol. 2015 Jun; 5 (3):85-9. DOI: 10.4236&#47;ojmm.2015.52010</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.4236&#47;ojmm.2015.52010</RefLink>
      </Reference>
      <Reference refNo="35">
        <RefAuthor>Jain M</RefAuthor>
        <RefAuthor>Sharma A</RefAuthor>
        <RefAuthor>Sen MK</RefAuthor>
        <RefAuthor>Rani V</RefAuthor>
        <RefAuthor>Gaind R</RefAuthor>
        <RefAuthor>Suri JC</RefAuthor>
        <RefTitle>Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients</RefTitle>
        <RefYear>2019</RefYear>
        <RefJournal>Microb Pathog</RefJournal>
        <RefPage>75-81</RefPage>
        <RefTotal>Jain M, Sharma A, Sen MK, Rani V, Gaind R, Suri JC. Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients. Microb Pathog. 2019 Mar;128:75-81. DOI: 10.1016&#47;j.micpath.2018.12.023</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;j.micpath.2018.12.023</RefLink>
      </Reference>
      <Reference refNo="36">
        <RefAuthor>Liao Q</RefAuthor>
        <RefAuthor>Feng Z</RefAuthor>
        <RefAuthor>Lin H</RefAuthor>
        <RefAuthor>Zhou Y</RefAuthor>
        <RefAuthor>Lin J</RefAuthor>
        <RefAuthor>Zhuo H</RefAuthor>
        <RefAuthor>Chen X</RefAuthor>
        <RefTitle>Carbapenem-resistant gram-negative bacterial infection in intensive care unit patients: Antibiotic resistance analysis and predictive model development</RefTitle>
        <RefYear>2023</RefYear>
        <RefJournal>Front Cell Infect Microbiol</RefJournal>
        <RefPage>1109418</RefPage>
        <RefTotal>Liao Q, Feng Z, Lin H, Zhou Y, Lin J, Zhuo H, Chen X. Carbapenem-resistant gram-negative bacterial infection in intensive care unit patients: Antibiotic resistance analysis and predictive model development. Front Cell Infect Microbiol. 2023;13:1109418. DOI: 10.3389&#47;fcimb.2023.1109418</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.3389&#47;fcimb.2023.1109418</RefLink>
      </Reference>
      <Reference refNo="37">
        <RefAuthor>Patrier J</RefAuthor>
        <RefAuthor>Timsit JF</RefAuthor>
        <RefTitle>Carbapenem use in critically ill patients</RefTitle>
        <RefYear>2020</RefYear>
        <RefJournal>Curr Opin Infect Dis</RefJournal>
        <RefPage>86&#8211;91</RefPage>
        <RefTotal>Patrier J, Timsit JF. Carbapenem use in critically ill patients. Curr Opin Infect Dis. 2020 Feb;33(12):86&#8211;91. DOI: 10.1097&#47;QCO.0000000000000622</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1097&#47;QCO.0000000000000622</RefLink>
      </Reference>
      <Reference refNo="38">
        <RefAuthor>Muller A</RefAuthor>
        <RefAuthor>Bertrand X</RefAuthor>
        <RefAuthor>Rogues AM</RefAuthor>
        <RefAuthor>P&#233;fau M</RefAuthor>
        <RefAuthor>Alfandari S</RefAuthor>
        <RefAuthor>Gauzit R</RefAuthor>
        <RefTitle>Higher third-generation cephalosporin prescription proportion is associated with lower probability of reducing carbapenem use: a nationwide retrospective study</RefTitle>
        <RefYear>2018</RefYear>
        <RefJournal>Antimicrob Resist Infect Control</RefJournal>
        <RefPage>11</RefPage>
        <RefTotal>Muller A, Bertrand X, Rogues AM, P&#233;fau M, Alfandari S, Gauzit R. Higher third-generation cephalosporin prescription proportion is associated with lower probability of reducing carbapenem use: a nationwide retrospective study. Antimicrob Resist Infect Control. 2018 Jan 22;7:11. DOI: 10.1186&#47;s13756-018-0302-8</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1186&#47;s13756-018-0302-8</RefLink>
      </Reference>
      <Reference refNo="39">
        <RefAuthor>Rosenthal VD</RefAuthor>
        <RefAuthor>Guzman S</RefAuthor>
        <RefAuthor>Crnich C</RefAuthor>
        <RefTitle>Impact of an infection control program on rates of ventilator-associated pneumonia in intensive care units in 2 Argentinean hospitals</RefTitle>
        <RefYear>2006</RefYear>
        <RefJournal>Am J Infect Control</RefJournal>
        <RefPage>58-63</RefPage>
        <RefTotal>Rosenthal VD, Guzman S, Crnich C. Impact of an infection control program on rates of ventilator-associated pneumonia in intensive care units in 2 Argentinean hospitals. Am J Infect Control. 2006 Mar;34(2):58-63. DOI: 10.1016&#47;j.ajic.2005.11.002</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;j.ajic.2005.11.002</RefLink>
      </Reference>
      <Reference refNo="40">
        <RefAuthor>&#193;lvarez-Lerma F</RefAuthor>
        <RefAuthor>S&#225;nchez Garc&#237;a M</RefAuthor>
        <RefAuthor> Task Force of Experts for Project &#8220;Zero VAP&#8221; in Spain</RefAuthor>
        <RefTitle>&#8220;The multimodal approach for ventilator-associated pneumonia prevention&#8221;&#8212;requirements for nationwide implementation</RefTitle>
        <RefYear>2018</RefYear>
        <RefJournal>Ann Transl Med</RefJournal>
        <RefPage>420</RefPage>
        <RefTotal>&#193;lvarez-Lerma F, S&#225;nchez Garc&#237;a M; Task Force of Experts for Project &#8220;Zero VAP&#8221; in Spain. &#8220;The multimodal approach for ventilator-associated pneumonia prevention&#8221;&#8212;requirements for nationwide implementation. Ann Transl Med. 2018 Nov;6(21):420. DOI: 10.21037&#47;atm.2018.08.40</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.21037&#47;atm.2018.08.40</RefLink>
      </Reference>
      <Reference refNo="41">
        <RefAuthor>Obaid NA</RefAuthor>
        <RefTitle>Preventive measures and management of catheter-associated urinary tract infection in adult intensive care units in Saudi Arabia: J Epidemiol Glob Health</RefTitle>
        <RefYear>2021</RefYear>
        <RefTotal>Obaid NA. Preventive measures and management of catheter-associated urinary tract infection in adult intensive care units in Saudi Arabia: J Epidemiol Glob Health. 2021 Jun;11(2):164-8. DOI: 10.2991&#47;jegh.k.210418.001</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.2991&#47;jegh.k.210418.001</RefLink>
      </Reference>
      <Reference refNo="42">
        <RefAuthor>Iordanou S</RefAuthor>
        <RefAuthor>Middleton N</RefAuthor>
        <RefAuthor>Papathanassoglou E</RefAuthor>
        <RefAuthor>Raftopoulos V</RefAuthor>
        <RefTitle>Surveillance of device associated infections and mortality in a major intensive care unit in the Republic of Cyprus</RefTitle>
        <RefYear>2017</RefYear>
        <RefJournal>BMC Infect Dis</RefJournal>
        <RefPage>607</RefPage>
        <RefTotal>Iordanou S, Middleton N, Papathanassoglou E, Raftopoulos V. Surveillance of device associated infections and mortality in a major intensive care unit in the Republic of Cyprus. BMC Infect Dis. 2017 Sep 6;17(1):607. DOI: 10.1186&#47;s12879-017-2704-2</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1186&#47;s12879-017-2704-2</RefLink>
      </Reference>
    </References>
    <Media>
      <Tables>
        <Table format="png">
          <MediaNo>2</MediaNo>
          <MediaID>2</MediaID>
          <Caption><Pgraph><Mark1>Table 2: Reasons for anti-infective treatment (n&#61;50)</Mark1></Pgraph></Caption>
        </Table>
        <Table format="png">
          <MediaNo>3</MediaNo>
          <MediaID>3</MediaID>
          <Caption><Pgraph><Mark1>Table 3: Incidence of nosocomial infection sites in the overall cohort (n&#61;50)</Mark1></Pgraph></Caption>
        </Table>
        <Table format="png">
          <MediaNo>4</MediaNo>
          <MediaID>4</MediaID>
          <Caption><Pgraph><Mark1>Table 4: Distribution of the main bacteria responsible for nosocomial infections</Mark1></Pgraph></Caption>
        </Table>
        <Table format="png">
          <MediaNo>1</MediaNo>
          <MediaID>1</MediaID>
          <Caption><Pgraph><Mark1>Table 1: Invasive devices and surgical procedures</Mark1></Pgraph></Caption>
        </Table>
        <NoOfTables>4</NoOfTables>
      </Tables>
      <Figures>
        <NoOfPictures>0</NoOfPictures>
      </Figures>
      <InlineFigures>
        <NoOfPictures>0</NoOfPictures>
      </InlineFigures>
      <Attachments>
        <NoOfAttachments>0</NoOfAttachments>
      </Attachments>
    </Media>
  </OrigData>
</GmsArticle>